Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Change in Receivables: 2010-2013

Historic Change in Receivables for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Mar 2013 value amounting to -$1.4 million.

  • Sonoma Pharmaceuticals' Change in Receivables fell 1413.59% to -$1.4 million in Q1 2013 from the same period last year, while for Mar 2013 it was -$411,000, marking a year-over-year decrease of 350.61%. This contributed to the annual value of -$434,000 for FY2025, which is 288.70% down from last year.
  • As of Q1 2013, Sonoma Pharmaceuticals' Change in Receivables stood at -$1.4 million, which was down 670.89% from $237,000 recorded in Q4 2012.
  • Sonoma Pharmaceuticals' Change in Receivables' 5-year high stood at $1.2 million during Q2 2012, with a 5-year trough of -$1.4 million in Q1 2013.
  • Moreover, its 3-year median value for Change in Receivables was -$51,000 (2011), whereas its average is -$63,222.
  • In the last 5 years, Sonoma Pharmaceuticals' Change in Receivables spiked by 2,488.24% in 2012 and then slumped by 1,413.59% in 2013.
  • Sonoma Pharmaceuticals' Change in Receivables (Quarterly) stood at -$497,000 in 2010, then skyrocketed by 79.48% to -$102,000 in 2011, then skyrocketed by 332.35% to $237,000 in 2012, then tumbled by 1,413.59% to -$1.4 million in 2013.
  • Its Change in Receivables stands at -$1.4 million for Q1 2013, versus $237,000 for Q4 2012 and -$513,000 for Q3 2012.